Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Oncol Pract. 2018 Feb 13;14(3):e149–e157. doi: 10.1200/JOP.2017.027730

Figure 2.

Figure 2

Adjusted** average annual costs of cancer care for IDN vs. non-IDN hospitals at end of life

* p <0.05

**Adjusted for patient (age, sex, number of Charlson co-morbidities, marital status), hospital (geographic region, number of beds, urban/rural, hospital ownership, surgical volume), and cancer (stage, grade) characteristics